SPOP and prostate carcinoma: Similarly, Barbieri et al. [14] described that 6%–13% of localized primary prostate cancer samples harbor mutations in SPOP, a gene encoding the substrate-binding subunit of a cullin-based E3 ubiquitin ligase.